EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 3.0

Risk Stratification for Vancomycin-Associated Acute Kidney Injury in Chinese Adult Inpatients: A Multicenter Retrospective Cohort Study

Shu Chen iD, Ying Zhang, Xingyun Hou, Yuzhu Wang iD, Chengchun Zuo, Chengwei Huang, Xiaotong Xia, Chang Cao, Qianzhou Lv, Xiaoyu Li, Kunming Pan

Infection and Drug Resistance · 2026-07 · Volume 19 · 1-15

DOI: 10.2147/idr.s618586 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Infection and Drug Resistance, 2026-07. Verfasst von Shu Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, People's Republic of China. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Vancomycin-associated acute kidney injury (VA-AKI) remains a major safety concern during treatment of serious infections. We aimed to identify a clinically relevant vancomycin trough threshold associated with VA-AKI and to define factors associated with renal injury in Chinese adult inpatients. Patients and Methods: We conducted a multicenter retrospective cohort study of 2230 Chinese adult inpatients treated with intravenous vancomycin between 2016 and 2025. VA-AKI was defined according to Kidney Disease: Improving Global Outcomes criteria. Receiver operating characteristic analysis was used to identify the trough threshold associated with VA-AKI, and multivariable logistic regression was performed to assess factors independently associated with VA-AKI.

Results

VA-AKI occurred in 493/2230 patients (22.1%). The trough concentration most closely associated with VA-AKI was 15.9 mg/L (AUC 0.64). Compared with troughs 20 mg/L were associated with progressively higher AKI risk. Factors independently associated with VA-AKI included contrast exposure, concomitant piperacillin-tazobactam or cephalosporin therapy, critical illness, treatment duration ≥14 days, cardiac dysfunction, and baseline renal impairment. VA-AKI was also associated with worse outcomes, including higher 60-day mortality (16% vs 4%) and greater dialysis requirement (6% vs 2%).

Conclusion

In this large multicenter cohort, VA-AKI occurred in approximately one in five Chinese adult inpatients receiving vancomycin. A vancomycin trough concentration of approximately 15.9 mg/L may serve as a practical threshold for early AKI risk stratification, particularly in clinical settings where AUC-guided monitoring is not routinely available. Closer renal surveillance may be warranted in patients with additional treatment-related or clinical risk factors. Vancomycin is an essential antibiotic for treating severe infections, but it can also damage the kidneys, especially in hospitalized patients. This large multicenter study from China shows that kidney injury during vancomycin treatment is common and linked to much worse outcomes, including higher risk of death and dialysis. Importantly, the study identifies a practical blood concentration level above which the risk of kidney injury rises substantially, even within the range often considered acceptable in routine care. It also highlights other common clinical factors that further increase risk, such as poor baseline kidney function, critical illness, and use of certain combination drugs. These findings provide clinicians with clearer, more practical guidance for safer vancomycin use and support earlier monitoring and intervention in patients at greatest risk.

Schlagwörter

Stichwörter der Autor:innen

acute kidney injurymulticenter cohort studyrisk factorstherapeutic drug monitoringvancomycin

Autor:innen und Institutionen

  • Department of Pharmacy, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, People's Republic of China.
  • Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
  • Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai, People's Republic of China.
  • Department of Medical Informatics, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, People's Republic of China.

ORCID-Profile: Shu Chen, Yuzhu Wang

Zitieren

APA

Chen, S., Zhang, Y., Hou, X., Wang, Y., Zuo, C., Huang, C., Xia, X., Cao, C., Lv, Q., Li, X., & Pan, K. (2026). Risk Stratification for Vancomycin-Associated Acute Kidney Injury in Chinese Adult Inpatients: A Multicenter Retrospective Cohort Study. Infection and Drug Resistance, Volume 19, 1-15. https://doi.org/10.2147/idr.s618586

Vancouver

Chen S, Zhang Y, Hou X, Wang Y, Zuo C, Huang C, et al. Risk Stratification for Vancomycin-Associated Acute Kidney Injury in Chinese Adult Inpatients: A Multicenter Retrospective Cohort Study. Infection and Drug Resistance. 2026;Volume 19:1-15. doi:10.2147/idr.s618586

BibTeX
@article{Chen2026,
  author = {Chen, Shu and Zhang, Ying and Hou, Xingyun and Wang, Yuzhu and Zuo, Chengchun and Huang, Chengwei and Xia, Xiaotong and Cao, Chang and Lv, Qianzhou and Li, Xiaoyu and Pan, Kunming},
  title = {Risk Stratification for Vancomycin-Associated Acute Kidney Injury in Chinese Adult Inpatients: A Multicenter Retrospective Cohort Study},
  journal = {Infection and Drug Resistance},
  year = {2026},
  volume = {Volume 19},
  pages = {1--15},
  doi = {10.2147/idr.s618586}
}
Kostenlos starten →